Search

Your search keyword '"Woodward N"' showing total 303 results

Search Constraints

Start Over You searched for: Author "Woodward N" Remove constraint Author: "Woodward N"
303 results on '"Woodward N"'

Search Results

1. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

2. Magnetism-induced massive Dirac spectra and topological defects in the surface state of Cr-doped Bi$_2$Se$_3$-bilayer topological insulators

3. MINERvA neutrino detector response measured with test beam data

5. Design, Calibration, and Performance of the MINERvA Detector

6. Measurement of Muon Neutrino Quasi-Elastic Scattering on a Hydrocarbon Target at E_{\nu} ~ 3.5 GeV

7. Measurement of Muon Antineutrino Quasi-Elastic Scattering on a Hydrocarbon Target at E_{\nu} ~ 3.5 GeV

8. The empty pelvis syndrome: a core data set from the PelvEx collaborative.

9. Optimization and Geophysical Inverse Problems

10. MINERvA neutrino detector response measured with test beam data

11. Design, calibration, and performance of the MINERvA detector

13. Pharmacokinetic profile and effect on the faecal microbiome of a single dose of pradofloxacin oral suspension in the rabbit (Oryctolagus cuniculus).

19. Potential Impact of the 2016 Consensus Definitions of Sepsis and Septic Shock on Future Sepsis Research

20. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

24. Gender differences in mortality and quality of life after septic shock: A post-hoc analysis of the ARISE study

29. Xenobiotics and Food-Producing Animals

32. Genetic determinants of circulating glycine levels and risk of coronary artery disease

36. Abstract P6-18-12: EMBRACA: Efficacy and safety of talazoparib or physician's choice of therapy in patients with advanced breast cancer and a germline BRCA1/2 mutation: A regional analysis

37. Basic Research Needs for Geosciences: Facilitating 21st Century Energy Systems

40. The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program

43. Coping With Minor Casualties

44. Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: An exploratory randomized phase II trial.

46. Abstract OT2-01-13: A phase 3, open-label, randomized, 2-arm international study of the oral dual PARP inhibitor talazoparib in germline BRCA mutation subjects with locally advanced and/or metastatic breast cancer (EMBRACA)

48. Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models

49. Management of patients treated with pertuzumab in the Australian clinical practice setting.

50. Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape

Catalog

Books, media, physical & digital resources